Friday 6 November 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue: +10.9%
EPS: −351.9%
Free cash flow: −11.5%
Total debt: +3.28%

Quarter to September 2026, against a year earlier

174.11 5.63 +3.34%

Follow RGEN

Alert me

Market cap: $10.8B
P/E: 0.0×
Fwd P/E: −615×
Dividend yield: —
F-score: 6/9
Altman Z: 7.49
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Repligen Corporation 10-K filed Mar 14, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Mar 14, 2025 · accepted 7:14 PM ET · Document on sec.gov · Filing index

Red flags

Restatement Mar 14, 2025
Repligen Corporation’s 10-K corrects an error in previously issued financial statements

10-K filed Mar 14, 2025 · The filing · sec.gov